Compound Muscle Action Potential amplitude reproducibility as a function of site and size of the recording electrode.

Completed

• Conditions: not applicable; 10028302

• Registration Number: NL-OMON34506
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

aged between 18 and 50

Exclusion Criteria

evidence of diseases of or predisposing to peripheral nerve damage of the leg

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>CMAP parameters (latency, duration, amplitude and area of distally evoked<br /><br>CMAPs) as well as conduction parameters (motor nerve conduction velocity<br /><br>(MNCV), and the percentile changes of amplitude, duration and area over the<br /><br>length of nerve) described as means with standard deviation (SD), as well as<br /><br>with the coefficient of variation (CV). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>